Insider filing · GRAL
Aaron Freidin
Chief Financial Officer
profile →
GRAIL, Inc.
GRAL · Healthcare · 33 filings in 24 months
ticker →
Aaron Freidin sold $2.5M of GRAIL (GRAL)
Executed Dec 3 2025, disclosed Dec 5 2025, 2 days later.
Value, as filed
$2.5M
25,000 sh × $99.15
Executed
Dec 3 2025
the trade date, as filed
Disclosed
Dec 5 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AFAaron Freidin (Chief Financial Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in GRAIL, Inc. (GRAL). The largest single filing was $2.5M of GRAL (25,000 sh × $99.15, as filed), executed Dec 3 2025.
The name
GRALHealthcare · GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and int…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Aaron Freidin in GRAL
GRALSALE
GRAIL, Inc.
$672K7,900 sh × $85.01
Exec Aug 27
Filed Aug 31 · 8:07 PM ET GRALSALE GRAIL, Inc. $2.3M
45,806 sh × $49.92
Exec Apr 8
Filed Apr 9 · 5:30 PM ET GRALSALE GRAIL, Inc. $115K
2,407 sh × $47.93
Exec Mar 9
Filed Mar 9 · 5:30 PM ET GRALSALE GRAIL, Inc. $458K
9,135 sh × $50.09
Exec Mar 2
Filed Mar 3 · 5:30 PM ET GRALSALE GRAIL, Inc. $134K
1,697 sh × $79.20
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET GRALSALE GRAIL, Inc. $311K
8,000 sh × $38.93
Exec Jul 15 2025
Filed Jul 17 2025 · 5:30 PM ET GRALSALE GRAIL, Inc. $1.4M
41,150 sh × $33.93
Exec May 2 2025
Filed May 5 2025 · 5:30 PM ET GRALSALE GRAIL, Inc. $427K
30,452 sh × $14.02
Exec Nov 18 2024
Filed Nov 19 2024 · 5:30 PM ET